FDA.reportPublic FDA data

HIBERIX vaccine 0.5 ML Injection

RxCUI
1300810
RxNorm name
HIBERIX vaccine 0.5 ML Injection
Display name
HIBERIX vaccine 0.5 ML Injection
Full name
HIBERIX vaccine 0.5 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125347HiberixHaemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
745ff8df-1618-4b76-9aa1-6f42752c0ddaHIBERIX vaccine 0.5 ML InjectionPSN22These highlights do not include all the information needed to use HIBERIX safely and effectively. See full prescribing information for HIBERIX. HIBERIX [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] for injection, for intramuscular use Initial U.S. Approval: 200920250121
745ff8df-1618-4b76-9aa1-6f42752c0ddaHiberix (Haemophilus influenzae type b strain 20,752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine) 35 MCG per 0.5 ML InjectionSY22These highlights do not include all the information needed to use HIBERIX safely and effectively. See full prescribing information for HIBERIX. HIBERIX [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] for injection, for intramuscular use Initial U.S. Approval: 200920250121
745ff8df-1618-4b76-9aa1-6f42752c0dda0.5 ML Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection [Hiberix]SBD22These highlights do not include all the information needed to use HIBERIX safely and effectively. See full prescribing information for HIBERIX. HIBERIX [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] for injection, for intramuscular use Initial U.S. Approval: 200920250121
745ff8df-1618-4b76-9aa1-6f42752c0dda0.5 ML Hiberix 0.07 MG/ML InjectionSY22These highlights do not include all the information needed to use HIBERIX safely and effectively. See full prescribing information for HIBERIX. HIBERIX [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] for injection, for intramuscular use Initial U.S. Approval: 200920250121
745ff8df-1618-4b76-9aa1-6f42752c0ddaHiberix (Haemophilus influenzae type b strain 20,752, capsular polysaccharide (10 MCG) inactivated tetanus toxoid (25 MCG) conjugate vaccine) per 0.5 ML InjectionSY22These highlights do not include all the information needed to use HIBERIX safely and effectively. See full prescribing information for HIBERIX. HIBERIX [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] for injection, for intramuscular use Initial U.S. Approval: 200920250121